574 filings
S-1
AGRX
Agile Therapeutics Inc
IPO registration
14 Jun 24
4:40pm
25-NSE
The Nasdaq Stock Market LLC
3 Jun 24
Exchange delisting
3:40pm
8-K
AGRX
Agile Therapeutics Inc
21 May 24
Entry into a Material Definitive Agreement
8:30am
10-Q
2024 Q1
AGRX
Agile Therapeutics Inc
Quarterly report
15 May 24
4:30pm
8-K
AGRX
Agile Therapeutics Inc
15 May 24
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:15pm
8-K
oxp4d 9ox73mhqtelx
9 Apr 24
Results of Operations and Financial Condition
8:30am
8-K
rq05xw
28 Mar 24
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
9:06am
8-K
5smxo0ltuo
25 Mar 24
Agile Therapeutics Announces Delisting from Nasdaq
4:30pm
8-K
g2l6p 0csr6
14 Mar 24
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
4:45pm
424B5
0wx2 hvatk7
23 Feb 24
Prospectus supplement for primary offering
4:57pm
424B5
4n84zm3z80ox9fo28
23 Feb 24
Prospectus supplement for primary offering
4:55pm
8-K
3ovjrxqknxzon q5e2jf
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
8-K
ek7sn
15 Feb 24
Net Revenue for Full Year 2023 Expected to be in the Range of $20 to $21 Million, an Increase of 84% to 93% Compared to Full Year 2022
4:45pm
SC 13G/A
rtxl9cfvny
13 Feb 24
AGILE THERAPEUTICS / Lind Global Fund II ownership change
8:02pm
SC 13G/A
c2v71h1qr6lsqhdper4i
6 Feb 24
AGILE THERAPEUTICS / INTRACOASTAL CAPITAL ownership change
10:14am